Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Encaleret in Chronic Hypoparathyroidism
NCT07805356Phase 3Recruiting
- Sponsor
- Calcilytix Therapeutics
- Start
- Aug 2026
- Primary completion
- Jan 2028
- Countries
- 2
01
Overview
A Phase 3 trial of encaleret in chronic hypoparathyroidism, sponsored by Calcilytix Therapeutics. Started Aug 2026; status: recruiting.
02
Drugs
encaleret
03
Conditions
chronic hypoparathyroidism
Beyond the preview
Go deeper on NCT07805356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07805356.